Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- Check2 days agoChange DetectedA government funding notice banner was added and the page revision tag updated to v3.4.1, while the previous revision tag v3.4.0 was removed.SummaryDifference0.5%

- Check9 days agoChange DetectedAdded a glossary toggle and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision indicator updated to v3.4.0. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. This reflects metadata updates rather than changes to the study data.SummaryDifference0.1%

- Check44 days agoChange DetectedA new Locations section including North Holland was added, and the HHS Vulnerability Disclosure and North Holland Locations entries were removed; the page revision updated to v3.3.3.SummaryDifference0.2%

- Check66 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No changes to the study details or substantive content.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.1. The previous wording stating publications come from PubMed (and the older revision v3.2.0) was removed.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.